ABSTRACT
Different species of adenoviruses (AdVs) infect humans and animals and are known for their role as pathogens, especially in humans, with animals, primarily rodents, often serving as model systems. However, although we know over 100 types of human AdVs, we know comparatively little about the diversity of animal AdVs. Due to the fact that rodents are the most diverse family of mammals and a standard model system for human disease, we set out to sample African rodents native to the Democratic Republic of the Congo and test them for AdV DNA using a semi-nested consensus PCR. A total of 775 animals were tested, and viral DNA was detected in four of them. The AdV DNA found belongs to three different AdVs, all being closely related to murine adenovirus 2 (MAdV-2). Considering the genetic differences of the amplicon were 9%, 11% and 19% from MAdV-2 and at least 10% from each other, they seem to belong to up to three different novel types within the Murine mastadenovirus B species. This evidence of genetic diversity highlights the opportunities to isolate and study additional AdVs that infect rodents as models for AdV biology and pathology.
ABSTRACT
Hepatitis C (HCV) molecular epidemiology is documented poorly in central African countries. In response to this, a population-based study of 319 consenting adults resident in a remote village of Gabon was undertaken (mean age: 38 years; age range: 13-85+; sex ratio: 0.74). Screening for anti-HCV antibodies was performed using ELISA and recombinant immunoblot assay. Seropositive samples were assessed further with viral load and genotyping techniques. Sixty-six (20.7%) individuals were HCV seropositive. Viral loads ranged from 600 to 24.9 million IU/ml (median: 372,500). Seroprevalence and viral loads increased significantly with age (P < 10(-5) and P < 0.003, respectively). HCV sequences of the 5'UTR genome region were obtained from 60 (90.9%) samples and NS5B region sequences were obtained from 22 (36.6%) samples. All strains belonged to subtypes of genotype 4: 4e (72.7%), 4c (13.6%), 4p (4.5%), 4r (4.5%) and one unclassified genotype 4 strain. Evolutionary analysis of the subtype 4e sequences indicates a period of raised transmission during the early twentieth century.
Subject(s)
Hepacivirus/classification , Hepacivirus/isolation & purification , Hepatitis C/epidemiology , Hepatitis C/virology , 5' Untranslated Regions , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Enzyme-Linked Immunosorbent Assay , Female , Gabon/epidemiology , Genotype , Hepacivirus/genetics , Hepatitis C Antibodies/blood , Humans , Immunoblotting , Male , Middle Aged , Phylogeny , RNA, Viral/genetics , Rural Population , Sequence Analysis, DNA , Seroepidemiologic Studies , Viral Load , Viral Nonstructural Proteins/geneticsABSTRACT
BACKGROUND: Previous epidemiological studies of rural human populations in Gabon reveal a high prevalence of human hepatitis A, B, C and D viruses. In order to investigate the prevalence of the blood-born hepatitis viruses in apes and monkeys living in the same area, we performed an epidemiological survey of HBV, HCV and HDV in wild-born non-human primates. METHODS: We tested 441 wild-born non-human primates from Gabon and Congo and 132 imported monkeys for the presence of serological markers of HBV, HCV and HDV infections. RESULTS: None of Cercopithecidae monkeys were reactive against HBV/HDV and HCV. In contrast, 29.2% of wild-born great apes (154 chimpanzees and 14 gorillas) were positive for HBV serological markers. Nine chimpanzees were in the replicative phase of HBV infection. None of these HBV infected chimpanzees exhibited symptoms or significant changes in serum clinical chemistry related to HBV infection. CONCLUSIONS: The negativity to HCV-related viruses and the negativity of the Cercopithecidae species tested against HBV/HDV do not allow us to definitively rule out the presence of an animal counterpart of human hepatitis viruses in non-human primates.
Subject(s)
Cercopithecidae/virology , Gorilla gorilla/virology , Hepatitis Viruses/isolation & purification , Hepatitis, Viral, Animal/epidemiology , Hepatitis, Viral, Animal/virology , Pan troglodytes/virology , Animals , Congo/epidemiology , Gabon/epidemiologyABSTRACT
Non-invasive faecal sampling in the equatorial forest in Gabon allowed the first identification of the hepatitis B virus (HBV-Ch(RC170)) genome in samples collected from wild chimpanzees (Pan troglodytes troglodytes). The HBV-Ch(RCl70)sequence clustered with 100% bootstrap support with previous viral sequences obtained from Pan troglodytes subspecies. This is the first evidence of HBV infection in wild apes and confirms that the HBV-like strains thus far characterized in captive apes are directly related to those circulating in the wild.
Subject(s)
Feces/virology , Hepatitis B virus/isolation & purification , Hepatitis B/veterinary , Pan troglodytes/virology , Animals , Animals, Wild , Gabon , Genome, Viral , Hepadnaviridae/classification , Hepadnaviridae/genetics , Hepatitis B/transmission , Hepatitis B/virology , Hepatitis B virus/genetics , Phylogeny , Primate Diseases/diagnosis , Primate Diseases/virology , Sequence Analysis, DNAABSTRACT
The mandrill (Mandrillus sphinx) has been shown to be infected with an STLV-1 closely related to HTLV-1. Two distinct STLV-1 subtypes (D and F) infect wild mandrills with high overall prevalence (27.0%) but are different with respect to their phylogenetic relationship and parallel to the mandrills' geographic range. The clustering of these new STLV-1mnd sequences with HTLV-1 subtype D and F suggests first, past simian-to-human transmissions in Central Africa and second, that species barriers are easier to cross over than geographic barriers.
Subject(s)
Deltaretrovirus Infections/veterinary , Mandrillus/virology , Monkey Diseases/virology , Simian T-lymphotropic virus 1/classification , Amino Acid Sequence , Animals , Deltaretrovirus Infections/virology , Female , Gabon , Gene Products, tax/chemistry , Gene Products, tax/genetics , Male , Mandrillus/physiology , Molecular Sequence Data , Phylogeny , Sequence Analysis, DNA , Simian T-lymphotropic virus 1/genetics , Simian T-lymphotropic virus 1/pathogenicityABSTRACT
Hepatitis B and C infections are endemic in human population in central Africa, particularly in Gabon. The aim of this study was to determine the prevalence of hepatitis B virus (HBV) and eventual occurrence of hepatitis C virus (HBC)-related strains in a variety of wild-born non-human primates living in Gabon and Congo. Plasma samples were screened for HBV and HCV markers. A non-invasive method of DNA extraction from faeces followed by specific HBV-DNA amplification was developed to study this infection in wild troops of chimpanzees and gorillas. No HCV infection in non-human primates, wild-born or captive, was detected among 596 samples tested. No HBV infection could be detected in samples tested and obtained from Cercopithecidae. In contrast, 14.7 and 42.2% of wild-born chimpanzees in Gabon and Congo were infected with HBV or had evidence of past HBV infection. At Centre International de Recherches Médicales (CIRMF) Primate Centre, 32.1% of chimpanzees and gorillas were HBV positive or had evidence of past infection. In the cases with past infection, 5.9% wild-born and 8.3% at CIRMF harboured HBV-DNA despite the presence of neutralizing HbsAb. Together with previous findings, we confirm the high HBV prevalence not only in humans but also in chimpanzees and gorillas in Gabon and Congo.
Subject(s)
Hepatitis B/veterinary , Hepatitis C/veterinary , Primate Diseases/epidemiology , Primates/virology , Animals , DNA Primers , Electrophoresis, Agar Gel , Enzyme-Linked Immunosorbent Assay , Feces/virology , Gabon/epidemiology , Hepacivirus/immunology , Hepatitis B/epidemiology , Hepatitis B virus/genetics , Hepatitis B virus/immunology , Hepatitis C/epidemiology , Polymerase Chain Reaction , Prevalence , Primates/immunologyABSTRACT
Mandrillus sphinx, a large primate living in Cameroon and Gabon and belonging to the Papionini tribe, was reported to be infected by a simian immunodeficiency virus (SIV) (SIVmndGB1) as early as 1988. Here, we have identified a second, highly divergent SIVmnd (designated SIVmnd-2). Genomic organization differs between the two viral types; SIVmnd-2 has the additional vpx gene, like other SIVs naturally infecting the Papionini tribe (SIVsm and SIVrcm) and in contrast to the other SIVmnd type (here designated SIVmnd-1), which is more closely related to SIVs infecting l'hoest (Cercopithecus lhoesti lhoesti) and sun-tailed (Cercopithecus lhoesti solatus) monkeys. Importantly, our epidemiological studies indicate a high prevalence of both types of SIVmnd; all 10 sexually mature wild-living monkeys and 3 out of 17 wild-born juveniles tested were infected. The geographic distribution of SIVmnd seems to be distinct for the two types: SIVmnd-1 viruses were exclusively identified in mandrills from central and southern Gabon, whereas SIVmnd-2 viruses were identified in monkeys from northern and western Gabon, as well as in Cameroon. SIVmnd-2 full-length sequence analysis, together with analysis of partial sequences from SIVmnd-1 and SIVmnd-2 from wild-born or wild-living mandrills, shows that the gag and pol regions of SIVmnd-2 are closest to those of SIVrcm, isolated from red-capped mangabeys (Cercocebus torquatus), while the env gene is closest to that of SIVmnd-1. pol and env sequence analyses of SIV from a related Papionini species, the drill (Mandrillus leucophaeus), shows a closer relationship of SIVdrl to SIVmnd-2 than to SIVmnd-1. Epidemiological surveys of human immunodeficiency virus revealed a case in Cameroon of a human infected by a virus serologically related to SIVmnd, raising the possibility that mandrills represent a viral reservoir for humans similar to sooty mangabeys in Western Africa and chimpanzees in Central Africa.
Subject(s)
Membrane Glycoproteins , Papio/virology , Simian Immunodeficiency Virus/classification , Viral Envelope Proteins , Amino Acid Sequence , Animals , Animals, Wild , Base Sequence , DNA, Viral , Female , HIV Envelope Protein gp120/classification , HIV Envelope Protein gp120/genetics , Humans , Male , Molecular Sequence Data , Peptide Fragments/classification , Peptide Fragments/genetics , Phylogeny , Recombination, Genetic , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/genetics , Simian Immunodeficiency Virus/isolation & purificationABSTRACT
We developed a simple, rapid, inexpensive, and highly sensitive and specific strategy for the detection and lineage differentiation of primate lentiviruses (PIV-ELISA). It is based on the use of two indirect ELISA methods using synthetic peptides mapping the gp41/36 region (detection component) and the V3 region (differentiation component) of four lentivirus lineages, namely SIVcpz/HIV-1 (groups M, O, N, and SIVcpz-gab), SIVmnd, SIVagm, and SIVsm/SIVmac/HIV-2. This strategy was evaluated with panels of sera originating from both humans and nonhuman primates. The human reference panel consisted of 144 HIV Western blot (WB)-positive sera in which the corresponding virus had been genotyped (HIV-1: 72 group M, 28 group O, and 6 group N; HIV-2: 21 subtype A and 10 subtype B; and 7 HIV-1+2) and 105 HIV WB-negative samples. The nonhuman primate reference panel consisted of 24 sera from monkeys infected by viruses belonging to the four lineages included in the PIV-ELISA strategy (5 chimpanzees, 5 macaques, 8 mandrills, and 6 vervets) and 42 samples from seronegative animals. Additional field evaluation panels consisted of 815 human sera from Gabon, Cameroon, and France and 537 samples from 25 nonhuman primate species. All the samples from the two reference panels were correctly detected and discriminated by PIV-ELISA. In the human field evaluation panel, the gp41/36 component correctly identified all the test samples, with 98% specificity. The V3 component discriminated 206 HIV-1 group M, 98 group O, 12 group M+O, and 128 HIV-2 sera. In the primate field evaluation panel, both gp41/36 and V3 detected and discriminated all the WB-positive samples originating from monkeys infected with SIVcpz, SIVagm-ver, SIVmnd-1, SIVmnd-2, SIVdrl, or SIVsun. These results were confirmed by genotyping in every case. Four SIV-infected red-capped mangabeys (confirmed by PCR) were correctly identified by gp41/36, but only two reacted with the V3 peptides in the absence of a specific SIVrcm V3 peptide. Addition of a V3 SIVrcm peptide discriminated all the SIVrcm-positive samples. Fourteen Papio papio samples were positive for SIVsm gp 36 and by WB, but negative by PCR, whereas three Papio cynocephalus samples were positive by gp41/36 but indeterminate by WB and negative by PCR. This combined ELISA system is thus highly sensitive and specific for antibodies directed against HIV and SIV. In addition, the V3-based serotyping results always agreed with genotyping results. This method should prove useful for studies of lentivirus prevalence and diversity in human and nonhuman primates, and may also have the potential to detect previously undescribed SIVs.
Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Lentiviruses, Primate/classification , Peptide Mapping , Peptides , Simian Immunodeficiency Virus/immunology , Amino Acid Sequence , Animals , Chlorocebus aethiops/virology , Gene Products, env , Genotype , HIV Antigens/immunology , HIV Envelope Protein gp120 , HIV Envelope Protein gp41 , Humans , Lentiviruses, Primate/immunology , Macaca/virology , Molecular Sequence Data , Pan troglodytes/virology , Papio/virology , Peptide Fragments , Peptides/chemical synthesis , Peptides/immunology , Sensitivity and Specificity , Simian Immunodeficiency Virus/classification , env Gene Products, Human Immunodeficiency VirusABSTRACT
Thirty-four HIV-1-infected in-patients of the Hôpital Central des Forces Armées Congolaises, Brazzaville, Congo, hospitalized for suspected cerebral toxoplasmosis, have been evaluated for integrity of the blood-brain barrier, intrathecal synthesis of total IgG, toxoplasmic serology in blood and cerebrospinal fluid, and for intrathecal synthesis of IgG to Toxoplasma gondii. An empiric scale to gauge the possibility of clinical cerebral toxoplasmosis was used to classify the patients (+, +2, +3). Only an intrathecal synthesis of IgG to Toxoplasma gondii was found to be associated with suspected cerebral toxoplamosis: it was found in about 80% of patients, and more frequently in patients with a higher probability of disease. In contrast, alteration of the blood-brain barrier, intrathecal synthesis of total IgG and toxoplasmic serology in blood as well as in cerebrospinal fluid were not associated with suspected cerebral toxoplamosis. Taken together, these findings confirm that intrathecal synthesis of antitoxoplasmic antibodies of IgG isotype occurs in cerebral toxoplasmosis. Demonstration of intrathecal synthesis of antitoxoplasmic IgG antibodies could be used to confirm clinical diagnosis of cerebral toxoplamosis, especially in an African context, where sophisticated laboratory facilities are often lacking.
Subject(s)
Acquired Immunodeficiency Syndrome/complications , Antibodies, Protozoan/biosynthesis , Toxoplasma/immunology , Toxoplasmosis, Cerebral/diagnosis , Adult , Animals , Blood-Brain Barrier , Congo , Female , Humans , Immunoglobulin G/biosynthesis , Immunoglobulin G/blood , Immunoglobulin G/cerebrospinal fluid , Male , Middle Aged , Toxoplasmosis, Cerebral/complications , Toxoplasmosis, Cerebral/parasitologySubject(s)
Acquired Immunodeficiency Syndrome/epidemiology , HIV Infections/epidemiology , HTLV-I Infections/epidemiology , HTLV-II Infections/epidemiology , Urban Population/statistics & numerical data , Adolescent , Adult , Age Factors , Female , Gabon/epidemiology , HIV Seroprevalence , HIV-1 , Humans , Male , Middle Aged , Prevalence , Sex FactorsABSTRACT
OBJECTIVE: To determine the prevalence and clinical presentations of rheumatic manifestations in HIV-infected patients seen at a rheumatology department in Congo-Brazzaville. METHODS: Over a one-year period, all patients admitted to the Brazzaville Teaching Hospital's rheumatology unit underwent serologic testing for the HIV by ELISA confirmed by Western blot. Standard criteria were used to classify the inflammatory joint diseases seen during the study period. RESULTS: A total of 171 patients, 85 men and 86 women, were tested. The age range was 16 to 81 years, with a mean of 42.1 years. HIV tests were positive in 39 patients, 24 men and 15 women, with a mean age of 31.2 years, accounting for 22.8% of the overall patient population and for 35.1% of all patients with inflammatory rheumatic syndromes. HIV infection stage as determined based on Centers for Disease Control criteria was i.v. in 35 patients and II in the remaining four patients. Of the 39 HIV-positive patients, 32 had HIV-related arthritis, two had reactive arthritis, two had staphylococcal septic arthritis and three had infectious discitis. Of the 72 HIV-negative patients with inflammatory rheumatic syndromes, 22 had septic arthritis, 18 had infectious discitis, five had reactive arthritis, four had rheumatoid arthritis, four had gout, two had poststreptococcal rheumatic disease, one had juvenile chronic arthritis and 16 had unclassifiable arthritis. None of the remaining 60 HIV-negative patients had inflammatory joint manifestations. CONCLUSION: HIV infection was both the leading reason for admission and the leading cause of arthritis. Acute, febrile, asymmetric, nondeforming, nonerosive polyarthritis of the small and large joints responsive to nonsteroidal antiinflammatory drug therapy was the most common clinical pattern of arthritis in HIV-positive patients. Reactive arthritis, septic arthritis and infectious discitis were rarely seen and had no specific features as compared to HIV-negative patients. Patients with arthritis should be tested for HIV infection. It follows that rheumatologists need to know how to provide counselling about HIV testing and how to disclose the results to their patients. They also need to be familiar with the management of HIV infection and to direct careful attention to the prevention of HIV transmission in health care facilities.
Subject(s)
Arthritis/epidemiology , Arthritis/virology , HIV Infections , Adolescent , Adult , Aged , Aged, 80 and over , Arthritis/diagnostic imaging , Congo/epidemiology , Female , HIV Infections/complications , HIV Seronegativity , Hospital Departments , Hospitals, Teaching , Humans , Male , Middle Aged , Prevalence , Radiography , Rheumatic Diseases/virology , RheumatologyABSTRACT
In a prior report, we described the isolation and characterization of SIVrcm, a distinct primate lentivirus found in a household pet Red-Capped Mangabey (RCM) in Gabon. SIVrcm is divergent from HIV-1 and HIV-2/SIV families of primate lentiviruses. In this report, additional in vitro replication studies and the results of SIVrcm infection in macaques are presented. SIVrcm causes little cytopathic effedct in Molt 4 Clone 8 cells and in rhesus and human PBMCs. In vivo, SIVrcm is non-pathogenic after 200 days in rhesus macaques and after one year in cynomolgous macaques, but does cause a chronic infection in both macaques.
Subject(s)
Cercocebus/virology , Simian Acquired Immunodeficiency Syndrome/physiopathology , Simian Immunodeficiency Virus/physiology , T-Lymphocyte Subsets/immunology , Virus Replication , Acquired Immunodeficiency Syndrome/immunology , Acquired Immunodeficiency Syndrome/physiopathology , Animals , Animals, Domestic , Antibody Formation , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , DNA, Viral/isolation & purification , Gabon , HIV-1/genetics , HIV-2/genetics , Humans , Lymphocyte Count , Macaca fascicularis , Polymerase Chain Reaction , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/genetics , Simian Immunodeficiency Virus/isolation & purificationSubject(s)
HIV Infections/virology , HIV-1/isolation & purification , HIV-2/isolation & purification , Acquired Immunodeficiency Syndrome/physiopathology , Acquired Immunodeficiency Syndrome/virology , Cross Reactions , Gabon , HIV Antibodies/blood , HIV Infections/epidemiology , HIV Infections/immunology , HIV-1/immunology , HIV-2/immunology , HumansABSTRACT
A seroprevalence survey was conducted for simian immunodeficiency virus (SIV) antibody in household pet monkeys in Gabon. Twenty-nine monkeys representing seven species were analyzed. By using human immunodeficiency virus type 2 (HIV-2)/SIVsm, SIVmnd, and SIVagm antigens, one red-capped mangabey (RCM) (Cercocebus torquatus torquatus) was identified as harboring SIV-cross-reactive antibodies. A virus isolate, termed SIVrcm, was subsequently established from this seropositive RCM by cocultivation of its peripheral blood mononuclear cells (PBMC) with PBMC from seronegative humans or RCMs. SIVrcm was also isolated by cocultivation of CD8-depleted RCM PBMC with Molt 4 clone 8 cells but not with CEMx174 cells. The lack of growth in CEMx174 cells distinguished this new SIV from all previously reported sooty mangabey-derived viruses (SIVsm), which grow well in this cell line. SIVrcm was also successfully transmitted (cell free) to human and rhesus PBMC as well as to Molt 4 clone 8 cells. To determine the evolutionary origins of this newly identified virus, subgenomic pol (475 bp) and gag (954 bp) gene fragments were amplified from infected cell culture DNA and sequenced. The position of SIVrcm relative to those of members of the other primate lentivirus lineages was then examined in evolutionary trees constructed from deduced protein sequences. This analysis revealed significantly discordant phylogenetic positions of SIVrcm in the two genomic regions. In trees derived from partial gag sequences, SIVrcm clustered independently from all other HIV and SIV strains, consistent with a new primate lentivirus lineage. However, in trees derived from pol sequences, SIVrcm grouped with the HIV-1/SIVcpz lineage. These findings suggest that the SIVrcm genome is mosaic and possibly is the result of a recombination event involving divergent lentiviruses in the distant past. Further analysis of this and other SIVrcm isolates may shed new light on the origin of HIV-1.
Subject(s)
Animals, Domestic/virology , Cercocebus/virology , Simian Acquired Immunodeficiency Syndrome/etiology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Immunodeficiency Virus/isolation & purification , Adaptation, Physiological , Animals , Antibodies, Viral/blood , Base Sequence , Cell Line , Cross Reactions , DNA Primers/genetics , Evolution, Molecular , Female , Gabon , Genes, gag , Genes, pol , HIV-2/immunology , Humans , In Vitro Techniques , Leukocytes, Mononuclear/virology , Macaca mulatta , Phylogeny , Simian Acquired Immunodeficiency Syndrome/immunology , Simian Immunodeficiency Virus/genetics , Simian Immunodeficiency Virus/immunology , Virus CultivationSubject(s)
HIV Infections/epidemiology , Age Factors , Child, Preschool , Congo/epidemiology , Humans , Incidence , InfantSubject(s)
HTLV-I Infections/epidemiology , HTLV-II Infections/epidemiology , Pregnancy Complications, Infectious/epidemiology , Adult , Blotting, Western , Cluster Analysis , Congo/epidemiology , Female , HTLV-I Antibodies/analysis , HTLV-II Antibodies/analysis , Humans , Pregnancy , Prevalence , Seroepidemiologic StudiesABSTRACT
334 prelevements ont ete realises dans le Service des Maladies Infectieuses de l'Hopital de Makelekele et testes en VIH et pour les marqueurs de l'hepatite B. Le but de l'etude etait de savoir s'il existait des liaisons significatives entre la presence des marqueurs de l'hepatite B et celui de l'infection a VIH. La majorite des patients; 286 de 334 patients (85;6 pour cent) etaient porteurs d'anticorps anti-HBc; ce qui prouve la frequence de l'infection VHB a Brazzaville. Mais on note que l'absence des marqueurs du virus de l'hepatite B etait liee avec l'absence de l'infection VIH (p=0;00003). La prevalence du portage de l'antigene HBs etait de 11;4 pour cent et les malades VIH negatifs etaient plus souvent porteurs de l'antigene HBs par rapport aux patients VIH positifs (16 vs 22; N.S.). L'antigene HBe etait plus souvent mis en evidence chez les patients co-infectes (HBV/VIH) que chez les patients infectes seulement par le virus de l'hepatite B (p=0;037)
Subject(s)
HIV Infections , Hepatitis B/diagnosisABSTRACT
Our objective was twofold: firstly to evaluate the impact of AIDS on the annual increase of tuberculosis morbidity in Brazzaville; and secondly, to show its consequences on the reduced availability of hospital beds for patients treated for diseases nonrelated to AIDS. This retrospective study included 541 tuberculosis patients who were treated from 1988 to 1992 in the Department of Medicine at the Military Central Hospital in Brazzaville. The serum of all patients was tested by ELISA and Western blots for the presence of HIV. HIV and tuberculosis coinfection were very frequent (more than 30% of all AIDS cases), particularly among young people (20-45 years old). Extrapulmonary tuberculosis cases (37%) have become almost as frequent as pulmonary tuberculosis forms (42.8%) among HIV positive patients, and the clinical picture is often atypical. Tuberculosis morbidity is increasing annually because of AIDS. The longer the tuberculosis patients with AIDS remain in the hospital, the fewer beds are available for other patients. For the public health programs against AIDS in developing countries, this is becoming an urgent problem to resolve.
Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Hospitalization/trends , Tuberculosis/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Bed Occupancy , Congo/epidemiology , Female , Hospitalization/statistics & numerical data , Humans , Male , Middle Aged , Population Surveillance , Prevalence , Retrospective StudiesABSTRACT
To assess the relationship between schistosomiasis and human immunodeficiency virus (HIV) infection, a cross-sectional study of HIV seroprevalence was carried out in 1992 in a village in the Bouenza region of the Congo where there is a high incidence of urinary schistosomiasis. No correlation was found between eggs in urine and positive serology for HIV in the 895 adults examined nor between positive schistosome serology and positive HIV serology. The incidence of frank schistosome infection (eggs in urine and positive blood tests) was significantly lower in patients with positive HIV serology (3.5%) than in patients with negative HIV serology (6.7%). Similarly the mean number of eggs in urine was significantly lower in patients with positive HIV serology (3.6 eggs per ml) than in patients with negative HIV serology (26.6 eggs per ml) (p < 0.01). These observations suggest that HIV infection limits schistosome development and decreases antibody production. Further study will be needed to confirm these findings.